Tag Archives: Data

Aiimi to showcase AI-driven data and information management solutions at Insight & Answers event

1.30pm, June 19th 2019, Sea Containers House, Upper Ground, London, SE1 9PD One of the most innovative names in the data and information market, Aiimi, is hosting a half-day conference on June 19th 2019 to discuss and assess trends in the market as well as bring together a host of organisations to give real-world insight… Read More »

Penn offers free machine learning platform to analyze data

The Penn Medicine Institute for Biomedical Informatics has launched a free, open-source automated artificial intelligence tool for both laymen and experts to conduct data analysis. “The problem with machine learning tools is that machine learning people build them, so they’re usually only usable by those with high levels of training,” says Jason Moore, director of… Read More »

New Zealand’s MOH to open up national health data with FHIR

New Zealand’s Ministry of Health will provide access to two core national systems – the National Health Index (NHI) and Health Practitioner Index (HPI) – using FHIR interfaces. Group manager digital strategy and investment Darren Douglass said that by improving access to these core data sets as FHIR resources, the Ministry expects to make it easier… Read More »

Hacker seeking Palmetto Health payroll info puts patient data at risk

An email phishing incident at Palmetto Health resulted in unauthorized access to certain employee email accounts, potentially affecting protected health information. The Pensacola, Fla.-based system is notifying 23,811 patients that an apparent attempt by a hacker to gain access to payroll information may have also impacted their health information. Patients of Palmetto Health, which recently… Read More »

XX Marks the Spot: Why Did Women Tech Experts Rule at DC Health Data Confab?

By MICHAEL L. MILLENSON Three government experts on a health tech conference panel discuss the urgency of releasing actionable data; all are women. A more senior official, another woman, gives a TED-style talk making the same case. And a four-person, private-sector panel debates privacy and ethics; three of the four are female. Health Datapalooza, a… Read More »

AstraZeneca, Merck's Lynparza plows ahead in ovarian cancer with $1B-plus approval, phase 3 data

The year may be winding down, but AstraZeneca and Merck’s Lynparza sure isn’t. It picked up a blockbuster new approval late Wednesday and followed up the act by posting positive phase 3 data Thursday morning. U.S. regulators green-lighted the fast-growing PARP inhibitor in BRCA-mutated ovarian cancer patients who’ve responded partially or completely to an initial… Read More »